A healthcare company focused on bone health

We are committed to helping patients maintain their mobility and independence

A healthcare company
focused on bone health

Breaking News

AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Find out more

About AgNovos

AgNovos Healthcare is focused on developing novel treatments to address bone disease, a crucial quality-of-life issue

Find out more

Clinical Research

AgNovos is  recruiting for clinical trial studies in Europe.  If you are a post-menopausal woman with osteoporosis and are interested in learning more about the study, please click below.

Find out more


OSSURE® LOEP® (Local Osteo-Enhancement Procedure) is a targeted approach to address local bone loss, including loss due to osteoporosis.

Find out more

The Agnovos Way

AgNovos is committed to act in a way that is consistent with our core values and commitment to helping patients and physicians confronting bone disease.  We will continually pursue new discoveries, technologies, and programs that improve bone health and education so that we can help families, communities, and the world move forward with more confidence.

Find out more


Our employees have the opportunity to grow professionally and personally as they work to help the company through each exciting phase of its growth.

Our talented, dedicated employees bring far more to the company than just their experience and expertise. They are deeply committed to our core goal: helping patients maintain their mobility, independence, and quality of life.​

Find out more